4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide
-
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide
structure -
-
CAS No:
36707-00-3
-
Formula:
C13H15N5O6
-
Chemical Name:
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide
-
Synonyms:
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide;4-Amino-5,8-dihydro-5-oxo-8-β-D-ribofuranosyl-pyrido[2,3-d]pyrimidine-6-carboxamide;API-1;NSC 177223;4-amino-8-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-oxopyrido[2,3-d]pyrimidine-6-carboxamide
- Categories:
-
CAS No:
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide Basic Attributes
337.2881
337.102233 g/mol
177223
DTXSID40306513
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide Use and Manufacturing
NSC 177223 is a Akt/protein kinase B inhibitor. It binds to pleckstrin homologous domain of Akt and blocks Akt membrane translocation. Treatment of cancer cells with NSC 177223 results in inhibition of the kinase activities and induction of cell growth arrest and apoptosis selectively in human cancer cells that harbor constitutively activated Akt.
Computed Properties
Molecular Weight:337.29
XLogP3:-1.9
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:3
Exact Mass:337.10223322
Monoisotopic Mass:337.10223322
Topological Polar Surface Area:185
Heavy Atom Count:24
Complexity:571
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
5'-deoxy-5'-thioinosine 5'-monophosphate
21959-63-7
-
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone
22003-30-1
-
5'-azacytidine5'-monophosphate
2226-72-4
-
Decarboxylated AdoMet Formula
22365-13-5
-
2′-Deoxy-6-thioinosine Formula
2239-64-7
-
Quercetin 3-glucuronide Formula
22688-79-5
-
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(methylamino)pyrimidin-2-one Structure
22882-02-6
-
Sucrose Structure
57-50-1
-
What is C18Dihydroceramide
2304-80-5
-
What is [5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl adamantane-1-carboxylate
23113-01-1
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide
SDSRequest for Quotation